Preimplantation Genetic Testing for Monogenic Disorders

Research output: Contribution to journalScientific review

3 Citations (Scopus)


Preimplantation genetic testing (PGT) has evolved into a well-established alternative to invasive prenatal diagnosis, even though genetic testing of single or few cells is quite challenging. PGT-M is in theory available for any monogenic disorder for which the disease-causing locus has been unequivocally identified. In practice, the list of indications for which PGT is allowed may vary substantially from country to country, depending on PGT regulation. Technically, the switch from multiplex PCR to robust generic workflows with whole genome amplification followed by SNP array or NGS represents a major improvement of the last decade: the waiting time for the couples has been substantially reduced since the customized preclinical workup can be omitted and the workload for the laboratories has decreased. Another evolution is that the generic methods now allow for concurrent analysis of PGT-M and PGT-A. As innovative algorithms are being developed and the cost of sequencing continues to decline, the field of PGT moves forward to a sequencing-based, all-in-one solution for PGT-M, PGT-SR, and PGT-A. This will generate a vast amount of complex genetic data entailing new challenges for genetic counseling. In this review, we summarize the state-of-the-art for PGT-M and reflect on its future.

Original languageEnglish
Article number871
Pages (from-to)1-15
Number of pages15
Issue number8
Publication statusPublished - Aug 2020


  • NGS
  • SNP array
  • monogenic disease
  • multiplex PCR
  • preimplantation genetic testing.

Fingerprint Dive into the research topics of 'Preimplantation Genetic Testing for Monogenic Disorders'. Together they form a unique fingerprint.

Cite this